The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
Introducing: Accelerator™ Drug Development, 360° CDMO and CRO solutions
Video
Jennifer Cannon, president of commercial operations, pharma services at Thermo Fisher Scientific, recently sat down to discuss our company’s newly launched approach to drug development: Accelerator™ Drug Development, 360° CDMO and CRO solutions. In the interview, Jennifer explains how we connect these services in a comprehensive and differentiated way.
By utilizing Accelerator™ Drug Development’s 360° CDMO and CRO solutions, over 80* biotech and biopharma companies have already experienced significant benefits, including reduced complexity and inefficiencies commonly found in traditional processes. Watch the video to learn more about our plans to bring Accelerator™ Drug Development to the pharma community.
*As of November 2024, this number is 120+.
See more:
Video